369 related articles for article (PubMed ID: 26243790)
21. Maximizing the extent of resection and survival benefit of patients in glioblastoma surgery: high-field iMRI versus conventional and 5-ALA-assisted surgery.
Roder C; Bisdas S; Ebner FH; Honegger J; Naegele T; Ernemann U; Tatagiba M
Eur J Surg Oncol; 2014 Mar; 40(3):297-304. PubMed ID: 24411704
[TBL] [Abstract][Full Text] [Related]
22. Safety and outcomes of resection of butterfly glioblastoma.
Dayani F; Young JS; Bonte A; Chang EF; Theodosopoulos P; McDermott MW; Berger MS; Aghi MK
Neurosurg Focus; 2018 Jun; 44(6):E4. PubMed ID: 29852771
[TBL] [Abstract][Full Text] [Related]
23. Residual tumor volume and patient survival following reoperation for recurrent glioblastoma.
Yong RL; Wu T; Mihatov N; Shen MJ; Brown MA; Zaghloul KA; Park GE; Park JK
J Neurosurg; 2014 Oct; 121(4):802-9. PubMed ID: 25061868
[TBL] [Abstract][Full Text] [Related]
24. When gross total resection of a glioblastoma is possible, how much resection should be achieved?
Chaichana KL; Cabrera-Aldana EE; Jusue-Torres I; Wijesekera O; Olivi A; Rahman M; Quinones-Hinojosa A
World Neurosurg; 2014; 82(1-2):e257-65. PubMed ID: 24508595
[TBL] [Abstract][Full Text] [Related]
25. Impact of treatment on survival of patients with secondary glioblastoma.
Hamisch C; Ruge M; Kellermann S; Kohl AC; Duval I; Goldbrunner R; Grau SJ
J Neurooncol; 2017 Jun; 133(2):309-313. PubMed ID: 28560660
[TBL] [Abstract][Full Text] [Related]
26. Is There an Indication for Intraoperative MRI in Subtotal Resection of Glioblastoma? A Multicenter Retrospective Comparative Analysis.
Coburger J; Segovia von Riehm J; Ganslandt O; Wirtz CR; Renovanz M
World Neurosurg; 2018 Feb; 110():e389-e397. PubMed ID: 29138078
[TBL] [Abstract][Full Text] [Related]
27. The Safety of Surgery in Elderly Patients with Primary and Recurrent Glioblastoma.
D'Amico RS; Cloney MB; Sonabend AM; Zacharia B; Nazarian MN; Iwamoto FM; Sisti MB; Bruce JN; McKhann GM
World Neurosurg; 2015 Oct; 84(4):913-9. PubMed ID: 26074434
[TBL] [Abstract][Full Text] [Related]
28. Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study.
Pessina F; Navarria P; Cozzi L; Tomatis S; Riva M; Ascolese AM; Santoro A; Simonelli M; Bello L; Scorsetti M
J Neurooncol; 2017 Jan; 131(2):377-384. PubMed ID: 27826681
[TBL] [Abstract][Full Text] [Related]
29. Surgical Resection of Anterior and Posterior Butterfly Glioblastoma.
Opoku-Darko M; Amuah JE; Kelly JJP
World Neurosurg; 2018 Feb; 110():e612-e620. PubMed ID: 29162526
[TBL] [Abstract][Full Text] [Related]
30. Multiple microsurgical resections for repeated recurrence of glioblastoma multiforme.
Hong B; Wiese B; Bremer M; Heissler HE; Heidenreich F; Krauss JK; Nakamura M
Am J Clin Oncol; 2013 Jun; 36(3):261-8. PubMed ID: 22495452
[TBL] [Abstract][Full Text] [Related]
31. Extent of resection of glioblastoma revisited: personalized survival modeling facilitates more accurate survival prediction and supports a maximum-safe-resection approach to surgery.
Marko NF; Weil RJ; Schroeder JL; Lang FF; Suki D; Sawaya RE
J Clin Oncol; 2014 Mar; 32(8):774-82. PubMed ID: 24516010
[TBL] [Abstract][Full Text] [Related]
32. Assessing the efficacy of repeat resections in recurrent glioblastoma: a systematic review.
Botros D; Dux H; Price C; Khalafallah AM; Mukherjee D
Neurosurg Rev; 2021 Jun; 44(3):1259-1271. PubMed ID: 32533385
[TBL] [Abstract][Full Text] [Related]
33. Impact of Laterality on Surgical Outcome of Glioblastoma Patients: A Retrospective Single-Center Study.
Coluccia D; Roth T; Marbacher S; Fandino J
World Neurosurg; 2018 Jun; 114():e121-e128. PubMed ID: 29510290
[TBL] [Abstract][Full Text] [Related]
34. Risk factors for glioblastoma therapy associated complications.
Ening G; Osterheld F; Capper D; Schmieder K; Brenke C
Clin Neurol Neurosurg; 2015 Jul; 134():55-9. PubMed ID: 25942630
[TBL] [Abstract][Full Text] [Related]
35. Association of Surgical Resection, Disability, and Survival in Patients with Glioblastoma.
Ahmadipour Y; Kaur M; Pierscianek D; Gembruch O; Oppong MD; Mueller O; Jabbarli R; Glas M; Sure U; El Hindy N
J Neurol Surg A Cent Eur Neurosurg; 2019 Jul; 80(4):262-268. PubMed ID: 30965373
[TBL] [Abstract][Full Text] [Related]
36. The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma.
Rahman M; Abbatematteo J; De Leo EK; Kubilis PS; Vaziri S; Bova F; Sayour E; Mitchell D; Quinones-Hinojosa A
J Neurosurg; 2017 Jul; 127(1):123-131. PubMed ID: 27689459
[TBL] [Abstract][Full Text] [Related]
37. Long-term therapy with temozolomide is a feasible option for newly diagnosed glioblastoma: a single-institution experience with as many as 101 temozolomide cycles.
Barbagallo GM; Paratore S; Caltabiano R; Palmucci S; Parra HS; Privitera G; Motta F; Lanzafame S; Scaglione G; Longo A; Albanese V; Certo F
Neurosurg Focus; 2014 Dec; 37(6):E4. PubMed ID: 25434389
[TBL] [Abstract][Full Text] [Related]
38. Surgical treatment of glioblastoma in the elderly: the impact of complications.
Karsy M; Yoon N; Boettcher L; Jensen R; Shah L; MacDonald J; Menacho ST
J Neurooncol; 2018 May; 138(1):123-132. PubMed ID: 29392589
[TBL] [Abstract][Full Text] [Related]
39. The relative value of postoperative versus preoperative Karnofsky Performance Scale scores as a predictor of survival after surgical resection of glioblastoma multiforme.
Chambless LB; Kistka HM; Parker SL; Hassam-Malani L; McGirt MJ; Thompson RC
J Neurooncol; 2015 Jan; 121(2):359-64. PubMed ID: 25344883
[TBL] [Abstract][Full Text] [Related]
40. The impact of repeated surgery and adjuvant therapy on survival for patients with recurrent glioblastoma.
De Bonis P; Fiorentino A; Anile C; Balducci M; Pompucci A; Chiesa S; Sica G; Lama G; Maira G; Mangiola A
Clin Neurol Neurosurg; 2013 Jul; 115(7):883-6. PubMed ID: 22959214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
